Skip to main content
Top
Published in: Implementation Science 1/2018

Open Access 01-12-2018 | Research

Why is announcement training more effective than conversation training for introducing HPV vaccination? A theory-based investigation

Authors: Teri L. Malo, Megan E. Hall, Noel T. Brewer, Christine R. Lathren, Melissa B. Gilkey

Published in: Implementation Science | Issue 1/2018

Login to get access

Abstract

Background

Improving healthcare providers’ communication about HPV vaccination is critical to increasing uptake. We previously demonstrated that training providers to use presumptive announcements to introduce HPV vaccination improved uptake, whereas training them to use participatory conversations had no effect. To understand how communication training changed provider perceptions and communication practices, we evaluated intermediate outcomes and process measures from our randomized clinical trial, with a particular focus on identifying mechanisms that might explain the announcement training’s impact.

Methods

In 2015, a physician educator delivered 1-h in-clinic HPV vaccination recommendation trainings at 20 primary care clinics in North Carolina serving 11,578 patients age 11 or 12. Clinics were randomized to receive training to use “announcements” that presume parents are ready to vaccinate or “conversations” that invite dialog about vaccination. Training participants were 83 HPV vaccine providers. Pre- and post-training surveys assessed constructs from the theory of planned behavior (TPB), including providers’ attitudes and subjective norms about HPV vaccination and their perceived behavioral control to recommend HPV vaccination. Surveys also assessed providers’ perceptions of the announcement and conversation communication strategies.

Results

Both trainings improved TPB-related constructs, including providers’ positive attitudes toward HPV vaccination, subjective norms, and perceived behavioral control to recommend the vaccine (all p < .001, Cohen’s d = .62–.90). Furthermore, in both trainings, the amount of time providers reported needing to discuss HPV vaccination with parents decreased from pre-training to 1-month follow-up (mean = 3.8 vs. 3.2 min, p = .01, d = .28). However, announcement trainings outperformed conversation trainings on other measures. For example, providers who received announcement training more often reported that the communication strategy saved them time, was easy to use, helped them promote HPV vaccination as routine care, and increased HPV vaccination coverage in their clinics (all p < .05; d = .44–.60).

Conclusions

Both announcement and conversation trainings improved providers’ HPV vaccine-related perceptions. However, providers viewed announcements as easier to use and more effective, which may help to explain the success of this training approach. Future provider communication interventions should consider implementation outcomes, including acceptability, alongside more traditional TPB constructs.

Trial registration

clinicaltrials.gov, NCT02377843. Registered on February 27, 2015.
Appendix
Available only for authorised users
Literature
1.
go back to reference Luckett R, Feldman S. Impact of 2-, 4- and 9-valent HPV vaccines on morbidity and mortality from cervical cancer. Hum Vaccin Immunother. 2016;12:1332–42.CrossRefPubMed Luckett R, Feldman S. Impact of 2-, 4- and 9-valent HPV vaccines on morbidity and mortality from cervical cancer. Hum Vaccin Immunother. 2016;12:1332–42.CrossRefPubMed
2.
go back to reference Garland SM, Kjaer SK, Munoz N, Block SL, Brown DR, DiNubile MJ, et al. Impact and effectiveness of the quadrivalent human papillomavirus vaccine: a systematic review of 10 years of real-world experience. Clin Infect Dis. 2016;63:519–27.CrossRefPubMedPubMedCentral Garland SM, Kjaer SK, Munoz N, Block SL, Brown DR, DiNubile MJ, et al. Impact and effectiveness of the quadrivalent human papillomavirus vaccine: a systematic review of 10 years of real-world experience. Clin Infect Dis. 2016;63:519–27.CrossRefPubMedPubMedCentral
3.
go back to reference Markowitz LE, Dunne EF, Saraiya M, Chesson HW, Curtis CR, Gee J, et al. Human papillomavirus vaccination: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep. 2014;63:1–30.PubMed Markowitz LE, Dunne EF, Saraiya M, Chesson HW, Curtis CR, Gee J, et al. Human papillomavirus vaccination: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep. 2014;63:1–30.PubMed
5.
go back to reference Meites E, Kempe A, Markowitz LE. Use of a 2-dose schedule for human papillomavirus vaccination— updated recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2016;65:1405–8.CrossRefPubMed Meites E, Kempe A, Markowitz LE. Use of a 2-dose schedule for human papillomavirus vaccination— updated recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2016;65:1405–8.CrossRefPubMed
6.
go back to reference Reagan-Steiner S, Yankey D, Jeyarajah J, Elam-Evans LD, Curtis CR, MacNeil J, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years—United States, 2015. MMWR Morb Mortal Wkly Rep. 2016;65:850–8.CrossRefPubMed Reagan-Steiner S, Yankey D, Jeyarajah J, Elam-Evans LD, Curtis CR, MacNeil J, et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years—United States, 2015. MMWR Morb Mortal Wkly Rep. 2016;65:850–8.CrossRefPubMed
7.
go back to reference Gilkey MB, Malo TL, Shah PD, Hall ME, Brewer NT. Quality of physician communication about human papillomavirus vaccine: findings from a national survey. Cancer Epidemiol Biomark Prev. 2015;24:1673–9.CrossRef Gilkey MB, Malo TL, Shah PD, Hall ME, Brewer NT. Quality of physician communication about human papillomavirus vaccine: findings from a national survey. Cancer Epidemiol Biomark Prev. 2015;24:1673–9.CrossRef
9.
go back to reference Gilkey MB, Moss JL, Coyne-Beasley T, Hall ME, Shah PD, Brewer NT. Physician communication about adolescent vaccination: how is human papillomavirus vaccine different? Prev Med. 2015;77:181–5.CrossRefPubMedPubMedCentral Gilkey MB, Moss JL, Coyne-Beasley T, Hall ME, Shah PD, Brewer NT. Physician communication about adolescent vaccination: how is human papillomavirus vaccine different? Prev Med. 2015;77:181–5.CrossRefPubMedPubMedCentral
10.
go back to reference Davis TC, Fredrickson DD, Arnold CL, Cross JT, Humiston SG, Green KW, et al. Childhood vaccine risk/benefit communication in private practice office settings: a national survey. Pediatrics. 2001;107:E17.CrossRefPubMed Davis TC, Fredrickson DD, Arnold CL, Cross JT, Humiston SG, Green KW, et al. Childhood vaccine risk/benefit communication in private practice office settings: a national survey. Pediatrics. 2001;107:E17.CrossRefPubMed
11.
go back to reference Dempsey AF, Lockhart S, Campagna EJ, Pyrzanowski J, Barnard J, O’Leary ST. Providers’ time spent and tools used when discussing the HPV vaccine with parents of adolescents. Vaccine. 2016;34:6217–22.CrossRefPubMed Dempsey AF, Lockhart S, Campagna EJ, Pyrzanowski J, Barnard J, O’Leary ST. Providers’ time spent and tools used when discussing the HPV vaccine with parents of adolescents. Vaccine. 2016;34:6217–22.CrossRefPubMed
12.
go back to reference Opel DJ, Robinson JD, Heritage J, Korfiatis C, Taylor JA, Mangione-Smith R. Characterizing providers' immunization communication practices during health supervision visits with vaccine-hesitant parents: a pilot study. Vaccine. 2012;30:1269–75.CrossRefPubMed Opel DJ, Robinson JD, Heritage J, Korfiatis C, Taylor JA, Mangione-Smith R. Characterizing providers' immunization communication practices during health supervision visits with vaccine-hesitant parents: a pilot study. Vaccine. 2012;30:1269–75.CrossRefPubMed
13.
go back to reference Henrikson NB, Opel DJ, Grothaus L, Nelson J, Scrol A, Dunn J, et al. Physician communication training and parental vaccine hesitancy: a randomized trial. Pediatrics. 2015;136:70–9.CrossRefPubMed Henrikson NB, Opel DJ, Grothaus L, Nelson J, Scrol A, Dunn J, et al. Physician communication training and parental vaccine hesitancy: a randomized trial. Pediatrics. 2015;136:70–9.CrossRefPubMed
14.
go back to reference Opel DJ, Heritage J, Taylor JA, Mangione-Smith R, Salas HS, Devere V, et al. The architecture of provider-parent vaccine discussions at health supervision visits. Pediatrics. 2013;132:1037–46.CrossRefPubMedPubMedCentral Opel DJ, Heritage J, Taylor JA, Mangione-Smith R, Salas HS, Devere V, et al. The architecture of provider-parent vaccine discussions at health supervision visits. Pediatrics. 2013;132:1037–46.CrossRefPubMedPubMedCentral
15.
go back to reference Opel DJ, Mangione-Smith R, Robinson JD, Heritage J, DeVere V, Salas HS, et al. The influence of provider communication behaviors on parental vaccine acceptance and visit experience. Am J Public Health. 2015;105:1998–2004.CrossRefPubMedPubMedCentral Opel DJ, Mangione-Smith R, Robinson JD, Heritage J, DeVere V, Salas HS, et al. The influence of provider communication behaviors on parental vaccine acceptance and visit experience. Am J Public Health. 2015;105:1998–2004.CrossRefPubMedPubMedCentral
16.
go back to reference Roberto AJ, Krieger JL, Katz ML, Goei R, Jain P. Predicting pediatricians’ communication with parents about the human papillomavirus (HPV) vaccine: an application of the theory of reasoned action. Health Commun. 2011;26:303–12.CrossRefPubMedPubMedCentral Roberto AJ, Krieger JL, Katz ML, Goei R, Jain P. Predicting pediatricians’ communication with parents about the human papillomavirus (HPV) vaccine: an application of the theory of reasoned action. Health Commun. 2011;26:303–12.CrossRefPubMedPubMedCentral
17.
go back to reference Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process. 1991;50:179–211.CrossRef Ajzen I. The theory of planned behavior. Organ Behav Hum Decis Process. 1991;50:179–211.CrossRef
18.
go back to reference Gilkey MB, Calo WA, Moss JL, Shah PD, Marciniak MW, Brewer NT. Provider communication and HPV vaccination: the impact of recommendation quality. Vaccine. 2016;34:1187–92.CrossRefPubMedPubMedCentral Gilkey MB, Calo WA, Moss JL, Shah PD, Marciniak MW, Brewer NT. Provider communication and HPV vaccination: the impact of recommendation quality. Vaccine. 2016;34:1187–92.CrossRefPubMedPubMedCentral
19.
go back to reference Brewer NT, Hall ME, Malo TL, Gilkey MB, Quinn B, Lathren C. Announcements versus conversations to improve HPV vaccination coverage: a randomized trial. Pediatrics. 2017;139:e20161764.CrossRefPubMedPubMedCentral Brewer NT, Hall ME, Malo TL, Gilkey MB, Quinn B, Lathren C. Announcements versus conversations to improve HPV vaccination coverage: a randomized trial. Pediatrics. 2017;139:e20161764.CrossRefPubMedPubMedCentral
21.
go back to reference Perkins RB, Clark JA, Apte G, Vercruysse JL, Sumner JJ, Wall-Haas CL, et al. Missed opportunities for HPV vaccination in adolescent girls: a qualitative study. Pediatrics. 2014;134:e666–74.CrossRefPubMed Perkins RB, Clark JA, Apte G, Vercruysse JL, Sumner JJ, Wall-Haas CL, et al. Missed opportunities for HPV vaccination in adolescent girls: a qualitative study. Pediatrics. 2014;134:e666–74.CrossRefPubMed
22.
go back to reference Liddon N, Michael SL, Dittus P, Markowitz LE. Maternal underestimation of child’s sexual experience: suggested implications for HPV vaccine uptake at recommended ages. J Adolesc Health. 2013;53:674–6.CrossRefPubMed Liddon N, Michael SL, Dittus P, Markowitz LE. Maternal underestimation of child’s sexual experience: suggested implications for HPV vaccine uptake at recommended ages. J Adolesc Health. 2013;53:674–6.CrossRefPubMed
23.
go back to reference Malo TL, Ali KN, Sutton SK, Perkins RB, Giuliano AR, Vadaparampil ST. The content and context of physicians’ communication with males about human papillomavirus vaccination. Hum Vaccin Immunother. 2016;12:1511–8.CrossRefPubMedPubMedCentral Malo TL, Ali KN, Sutton SK, Perkins RB, Giuliano AR, Vadaparampil ST. The content and context of physicians’ communication with males about human papillomavirus vaccination. Hum Vaccin Immunother. 2016;12:1511–8.CrossRefPubMedPubMedCentral
24.
go back to reference Williams DM, Dunsiger S. Suggestions for testing health behavior theories: implications for mediator analysis. Ann Behav Med. 2007;34:223.CrossRefPubMed Williams DM, Dunsiger S. Suggestions for testing health behavior theories: implications for mediator analysis. Ann Behav Med. 2007;34:223.CrossRefPubMed
25.
go back to reference Francis JJ, Eccles MP, Johnston M, Whitty P, Grimshaw JM, Kaner EF, et al. Explaining the effects of an intervention designed to promote evidence-based diabetes care: a theory-based process evaluation of a pragmatic cluster randomised controlled trial. Implement Sci. 2008;3:50.CrossRefPubMedPubMedCentral Francis JJ, Eccles MP, Johnston M, Whitty P, Grimshaw JM, Kaner EF, et al. Explaining the effects of an intervention designed to promote evidence-based diabetes care: a theory-based process evaluation of a pragmatic cluster randomised controlled trial. Implement Sci. 2008;3:50.CrossRefPubMedPubMedCentral
26.
go back to reference Grimshaw JM, Presseau J, Tetroe J, Eccles MP, Francis JJ, Godin G, et al. Looking inside the black box: results of a theory-based process evaluation exploring the results of a randomized controlled trial of printed educational messages to increase primary care physicians' diabetic retinopathy referrals [trial registration number ISRCTN72772651]. Implement Sci. 2014;9:86.CrossRefPubMedPubMedCentral Grimshaw JM, Presseau J, Tetroe J, Eccles MP, Francis JJ, Godin G, et al. Looking inside the black box: results of a theory-based process evaluation exploring the results of a randomized controlled trial of printed educational messages to increase primary care physicians' diabetic retinopathy referrals [trial registration number ISRCTN72772651]. Implement Sci. 2014;9:86.CrossRefPubMedPubMedCentral
27.
go back to reference Presseau J, Grimshaw JM, Tetroe JM, Eccles MP, Francis JJ, Godin G, et al. A theory-based process evaluation alongside a randomised controlled trial of printed educational messages to increase primary care physicians' prescription of thiazide diuretics for hypertension [ISRCTN72772651]. Implement Sci. 2016;11:121.CrossRefPubMedPubMedCentral Presseau J, Grimshaw JM, Tetroe JM, Eccles MP, Francis JJ, Godin G, et al. A theory-based process evaluation alongside a randomised controlled trial of printed educational messages to increase primary care physicians' prescription of thiazide diuretics for hypertension [ISRCTN72772651]. Implement Sci. 2016;11:121.CrossRefPubMedPubMedCentral
28.
go back to reference Ramsay CR, Thomas RE, Croal BL, Grimshaw JM, Eccles MP. Using the theory of planned behaviour as a process evaluation tool in randomised trials of knowledge translation strategies: a case study from UK primary care. Implement Sci. 2010;5:71.CrossRefPubMedPubMedCentral Ramsay CR, Thomas RE, Croal BL, Grimshaw JM, Eccles MP. Using the theory of planned behaviour as a process evaluation tool in randomised trials of knowledge translation strategies: a case study from UK primary care. Implement Sci. 2010;5:71.CrossRefPubMedPubMedCentral
29.
go back to reference Proctor E, Silmere H, Raghavan R, Hovmand P, Aarons G, Bunger A, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Admin Pol Ment Health. 2011;38:65–76.CrossRef Proctor E, Silmere H, Raghavan R, Hovmand P, Aarons G, Bunger A, et al. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Admin Pol Ment Health. 2011;38:65–76.CrossRef
Metadata
Title
Why is announcement training more effective than conversation training for introducing HPV vaccination? A theory-based investigation
Authors
Teri L. Malo
Megan E. Hall
Noel T. Brewer
Christine R. Lathren
Melissa B. Gilkey
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Implementation Science / Issue 1/2018
Electronic ISSN: 1748-5908
DOI
https://doi.org/10.1186/s13012-018-0743-8

Other articles of this Issue 1/2018

Implementation Science 1/2018 Go to the issue